Lotus Pharmaceuticals, Inc. (LTUS)

Market Cap	18.25M
Revenue (ttm)	71.39M
Net Income (ttm)	1.72M
Shares Out	2.64B
EPS (ttm)	0.06
PE Ratio	0.11
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	89,718
Average Volume	77,886
Open	0.0062
Previous Close	0.0050
Day's Range	0.0062 - 0.0077
52-Week Range	0.0006 - 0.0079
Beta	-2.49
RSI	55.09
Earnings Date	n/a

About Lotus Pharmaceuticals

Lotus Pharmaceuticals, Inc. does not have significant operations. Previously, it was engaged in the development, manufacture, and sale of pharmaceuticals in the People’s Republic of China. The company is based in Nashville, Tennessee.

• Industry: Shell Companies
• Sector: Financials
• CEO: Zhong Yi Liu
• Employees: 383
• Stock Exchange: OTCMKTS
• Ticker Symbol: LTUS

Financial Performance

In 2010, Lotus Pharmaceuticals's revenue was $72.70 million, an increase of 28.71% compared to the previous year's $56.48 million. Earnings were $14.42 million, a decrease of -12.22%.